On March 13, 2008, “The Epilepsy Pipeline Conference: Portal into CNS Opportunity” will be held in San Francisco. Sponsored by the Epilepsy Therapy Project (ETP), the day-long meeting will focus on drug development strategies, investing, and...
Steven C. Schachter, MD, received a special honor in India when he delivered the 28th T.S. Srinivasan Endowment Oration in Chennai on “Brainstorms Village-Meeting the Challenge of Disabling Epilepsy.” Quoted in India’s national newspaper, The...
When a Food and Drug Administration (FDA) alert was issued regarding antiepileptic drugs and suicidality, epilepsy.com responded with a Breaking News story and several articles to help patients put the findings in context. FDA Alert , 3 articles...
It was announced on February 27, 2008 that the U.S. Food and Drug Administration (FDA) has accepted Ovation Pharmaceuticals’ new drug applications (NDA) for Sabril® (vigabatrin) in two types of epilepsies. The FDA assigned a priority NDA review for...
On January 14, 2008 Dr. Steven Schachter was guest expert for a question and answer chat on seizure medicines. The purpose of this session was to provide general information and resources. These answers and the information on epilepsy.com are not...

Pages